Updating soon
Valuation
Market Cap
₹260.14 Cr
P/E Ratio
11.34x
P/B Ratio
3.71x
Pramodini Medicare IPO Dates
Conflicting IPOs
IPOs with overlapping timeline
Business Overview
Pramodini Medicare Limited is a technology-enabled diagnostic services provider incorporated in 2000 and headquartered in Vijayawada, Andhra Pradesh. It offers radiology (MRI, CT, X-ray, ultrasound, mammography, DEXA, intervention radiology), clinical laboratory and nuclear medicine (PET-CT, SPECT) services, along with 24x7 teleradiology. The company operates 16 diagnostic centres across 14 cities and 7 states through four models: Public-Private Partnership, Private-Private Partnership, Strategic Partnership with PSUs of the Government of India, and standalone Private Centres. Revenue is concentrated in radiology (~97%).
Lots & IPO Size
Pramodini Medicare IPO Lot Size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Ind (Min) | 2 | 2,400 | ₹2,83,200 |
| Ind (Max) | 2 | 2,400 | ₹2,83,200 |
| S-HNI (Min) | 3 | 3,600 | ₹4,24,800 |
| S-HNI (Max) | 7 | 8,400 | ₹9,91,200 |
| B-HNI (Min) | 8 | 9,600 | ₹11,32,800 |
Pramodini Medicare IPO Size
Objects of the Issue
Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres
General Corporate Purposes & issue expenses
Total
Key Risk Factors
The company derives a significant portion of its revenue from MOUs with government authorities under Public-Private Partnership arrangements; any adverse developments in these relationships could materially affect its business and financial condition.
Key Risk Factors
The company derives a significant portion of its revenue from MOUs with government authorities under Public-Private Partnership arrangements; any adverse developments in these relationships could materially affect its business and financial condition.
The company's concentrated emphasis on radiology services (~97% of revenue) exposes it to substantial risks that could adversely impact operations, financial performance and long-term growth prospects.
The company derives a substantial portion of its revenue from the state of Andhra Pradesh, and any loss of business in such regions could have an adverse effect on its results of operations and financial condition.
The company is majorly dependent on certain key customers cum patients for a substantial portion of its revenues, and the loss of one or more such customers could adversely affect its business.
The company derives a significant portion of its revenue from government authorities (B2G); any reduction in revenue from them could adversely affect its business and cash flows.
Failure to establish and comply with appropriate quality standards when performing diagnostic services could result in adverse effects on the company’s operations, reputation and financial performance.
The company relies on its information technology systems in providing diagnostic services and managing operations, and any disruption to such systems could adversely affect its business.
Any inadequacy in packaging, collection of, or failure or delay in the delivery of specimens to the company’s diagnostic centres could compromise or destroy the integrity of such specimens and adversely affect operations.
The company does not have any exact comparable listed Indian peer with a similar business, which may make it difficult for investors to benchmark its performance and valuation.
The company is required to furnish bank guarantees under its Strategic Partnership with PSU Govt of India; inability to arrange such guarantees or their invocation may adversely affect its cash flows and financial condition.
Pramodini Medicare IPO Details Live GMP
| Date | GMP (₹) | Est. Price |
|---|---|---|
| 07 Aug | ₹0 (0%) | ₹118 |
| 06 Aug | ₹0 (0%) | ₹118 |
| 05 Aug | ₹0 (0%) | ₹118 |
| 04 Aug | ₹0 (0%) | ₹118 |
Pramodini Medicare IPO Peer Comparison
(Rs. in crores)
| Particulars | Pramodini Medicare | Invicta Diagnostic | Krsnaa Diagnostics | Star Imaging & Path Labs |
|---|---|---|---|---|
| Revenue | 62.29 | 32.35 | 772.77 | 88.53 |
| PAT | 17.38 | 4.87 | 101.43 | 19.26 |
| EPS (₹) | 10.41 | 4.90 | 31.30 | 11.05 |
| NAV (₹) | 31.84 | 39.71 | 302.23 | 66.65 |
| RONW | 32.69% | 9.76% | 10.35% | 16.58% |
| EBITDA | 49.61% | 30.17% | 27.42% | 36.33% |
| PAT Mrgn | 27.90% | 15.06% | 13.13% | 21.75% |
| PE Ratio | 11.34 | 13.62 | 16.74 | 7.87 |
| Debt to Equity | 0.34 | 0.07 | 0.50 | 0.18 |
All information pertains to FY 2025-26. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of July 30, 2026 for Peers
Pramodini Medicare IPO Financial Performance
(Rs. in crores)
| Particulars | Mar-26 | Mar-25 | C |
|---|---|---|---|
| Revenue | 62.29 | 38.24 | 35.23 |
| PAT | 17.38 | 11.03 | 6.93 |
| Net Worth | 53.15 | 35.77 | 24.75 |
| Borrowings | 17.85 | 10.81 | 11.96 |
| Assets | 93.62 | 56.45 | 48.78 |
| NAV (₹) | 31.84 | 21.43 | 14.82 |
| EPS (₹) | 10.41 | 6.67 | 4.30 |
Key Performance Indicators (KPIs)
EBITDA
49.61%
PAT
27.90%
ROE
39.08%
ROCE
34.66%
Debt to Equity
0.34
All the data pertains to FY 2025-26. PE, PB, and market capitalization are calculated based on the Upper Price Band.
Pramodini Medicare IPO Financial Statements
(Rs. in crores)
| Particulars | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| Revenue from Ops | 62.29 | 38.24 | 35.23 |
| Other Income | 1.09 | 0.31 | 0.56 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Operating cost | 12.86 | 7.08 | 6.62 |
| Changes in Inventories | -0.79 | -0.17 | -0.01 |
| Employee Expense | 11.34 | 4.69 | 5.55 |
| Finance Costs | 1.30 | 1.24 | 1.63 |
| Depreciation | 7.39 | 4.28 | 4.39 |
| Other Expenses | 7.98 | 5.67 | 7.53 |
| Total Expenses | 40.08 | 22.80 | 25.72 |
| Profit Before Tax | 23.30 | 15.75 | 10.08 |
| Tax Expense | 5.92 | 4.61 | 2.94 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EPS — Basic (₹) | 10.41 | 6.67 | 4.30 |
| EPS — Diluted (₹) | 10.41 | 6.67 | 4.30 |
| Particulars | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| Equity Share Capital | 16.69 | 1.28 | 1.28 |
| Reserves & Surplus | 36.46 | 34.49 | 23.46 |
| Total Equity | 53.15 | 35.77 | 24.75 |
| Total Borrowings | 17.85 | 10.81 | 11.96 |
| Trade Payables | 0.82 | 0.56 | 4.02 |
| Other Liabilities | 21.79 | 9.30 | 8.05 |
| Total Equity & Liab | 93.62 | 56.45 | 48.78 |
| Fixed Assets | 44.21 | 21.79 | 16.03 |
| Trade Receivables | 17.40 | 11.17 | 17.94 |
| Cash & Bank Balances | 6.44 | 7.12 | 3.42 |
| Other Assets | 25.57 | 16.37 | 11.39 |
| Total Assets | 93.62 | 56.45 | 48.78 |
| Particulars | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| Cash Flow from Operating Activities | 25.39 | 22.12 | 9.85 |
| Cash Flow from Investing Activities | -30.63 | -14.66 | -1.38 |
| Cash Flow from Financing Activities | 5.73 | -2.39 | -10.81 |
| Net Change in Cash & Equivalents | 0.50 | 5.07 | -2.34 |
| Cash & Equivalents at End of Period | 6.37 | 5.87 | 0.80 |
Promoter Holding
Promoter
85.71%
Public
14.29%
Management
Chalasani Kuldeep Kumar
Age: 50
Chairman & MD
Remuneration
₹Rs.7.50L/mo (Oct25-Sep26), Rs.10.00L/mo (Oct26-Sep27), Rs.15.00L/mo (Oct27-Sep28) + perquisites up to Rs.50.00L p.a.
Education
MBBS (Nagpur Univ.); MD Radio-Diagnosis (RGUHS, Karnataka)
Prior Experience
20+ yrs in Medicine/Radio-Diagnosis; ex-Chief Resident, Grant Medical College & JJ Hospitals; ex-Associate Professor, Dr PSIMS&RF. With Company since 2015.
Rajkamal Kona
Age: 38
CFO
Remuneration
₹FY25-26 remuneration Rs.1.35 Lakhs (paid)
Education
M.Com (Acharya Nagarjuna University)
Prior Experience
12 yrs in accounts & finance; prior stints at NSIC, Chalam Heat Ex-Changers, Preca Solutions, Sarvani Industries. With Company since Jan 2026.
Potturi S.N.V. Krishna Kishore
Age: 45
COO
Remuneration
₹FY25-26 remuneration Rs.18.00 Lakhs (paid)
Education
BCA (Nagarjuna Univ.); Masters in Hospital Management (Osmania Univ.)
Prior Experience
18+ yrs in hospital administration; ex-Hospital Administrator at NRI Academy, Dr PSIMS&RF, GMR Varalakshmi CARE. With Company since Sep 2021.
Manmohan Gompa
Age: 41
CTO
Remuneration
₹FY25-26 remuneration Rs.12.75 Lakhs (paid)
Education
MBA Health Care Mgmt (Prist Univ.); MSc Applied Psychology; BSc Medical Imaging Tech (Manipal)
Prior Experience
18 yrs in CT/MRI; ex-CT/MRI Technician at Dr Ramesh Hospital, Dr PSIMS&RF; AERB-nominated Radiological Safety Officer. With Company since Nov 2015.
Registrar & Lead Managers
Registrar
Purva Share Registry
Lead Managers (1)
Company Details
Name: Pramodini Medicare Limited
Address: D. No: 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh, India, 520002
Number: +91 9985782727
Email: investors@pramodinidiagnostics.com
Website: https://www.pramodinidiagnostics.com
Explore More IPOs
Discover other active and upcoming IPOs.
Live IPOs
View AllOpening Soon
View AllRecently Closed
View AllFrequently Asked Questions (FAQs)
What is Pramodini Medicare IPO?
When will Pramodini Medicare IPO open?
What is the GMP of Pramodini Medicare IPO?
What is the lot size of Pramodini Medicare IPO?
When is the allotment of Pramodini Medicare IPO?
What is the listing date of Pramodini Medicare IPO?
What is the subscription of Pramodini Medicare IPO?
What is the price band of Pramodini Medicare IPO?
How to check allotment status of Pramodini Medicare IPO?
How to apply Pramodini Medicare IPO in Zerodha?
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
How to apply Pramodini Medicare IPO in Groww?
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
How to apply Pramodini Medicare IPO using ASBA?
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Pramodini Medicare IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
Delete Comment?
Are you sure you want to delete this comment? This action cannot be undone.
Discussion
Join the discussion!
Log In to CommentNo comments yet. Be the first to share your thoughts!